Business Segments · Total revenues
Business Segments — Total revenues
Amgen Business Segments — Total revenues decreased by 9.8% to $8.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $8.15B to $8.62B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2024
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market share or successful product launches, while a decrease may signal competitive pressure or patent expirations.
Detailed definition
Represents the total gross revenue generated by the company's primary business segments from the sale of biotechnology t...
Peer comparison
Standard across all pharmaceutical and biotech companies as 'Total Revenue' or 'Net Sales'.
Metric ID:
amgn_segment_reportable_segment_total_revenuesHistorical Data
7 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $7.45B | $8.39B | $8.50B | $8.15B | $9.18B | $9.56B | $8.62B |
| QoQ Change | — | +12.6% | +1.4% | -4.2% | +12.6% | +4.1% | -9.8% |
| YoY Change | — | — | — | +9.4% | +9.4% | +12.4% | +5.8% |
Range$7.45B – $9.56B
CAGR+10.2%
Avg YoY Growth+9.3%
Median YoY Growth+9.4%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's business segments — total revenues?
- Amgen (AMGN) reported business segments — total revenues of $8.62B in Q1 2026.
- How has Amgen's business segments — total revenues changed year-over-year?
- Amgen's business segments — total revenues increased by 5.8% year-over-year, from $8.15B to $8.62B.
- What does business segments — total revenues mean?
- The total amount of money generated from the sale of the company's products.